Article info

Download PDFPDF

Original article
Once-daily budesonide MMX in active, mild-to-moderate ulcerative colitis: results from the randomised CORE II study

Authors

  1. Correspondence to Dr Simon P L Travis, Translational Gastroenterology Unit, John Radcliffe Hospital, Oxford OX3 9DU, UK; simon.travis{at}ndm.ox.ac.uk
View Full Text

Citation

Travis SPL, Danese S, Kupcinskas L, et al
Once-daily budesonide MMX in active, mild-to-moderate ulcerative colitis: results from the randomised CORE II study

Publication history

  • Received December 4, 2012
  • Revised January 25, 2013
  • Accepted January 27, 2013
  • First published February 22, 2013.
Online issue publication 
February 04, 2014

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.